PTGX insider transaction filings
Protagonist Therapeutics, Inc — 48 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen PTGX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | PATEL DINESH V PH D — President and CEO, Director | Option exercise (M): 65,761 @ $21.58 · Sale (S): 65,761 @ $149.11 · Option exercise (M): 34,239 @ $21.58 · Sale (S): 34,239 @ $148.52 · Option exercise (M): 65,761 (derivative) @ $0 · Option exercise (M): 34,239 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Waddill William D. — Director | Option exercise (M): 9,000 @ $16.54 · Sale (S): 9,000 @ $117.94 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Waddill William D. — Director | Option exercise (M): 3,000 @ $11.80 · Option exercise (M): 6,000 @ $16.54 · Sale (S): 9,000 @ $107.68 · Option exercise (M): 3,000 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Waddill William D. — Director | Option exercise (M): 9,000 @ $11.80 · Sale (S): 9,000 @ $99.64 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4/A | PATEL DINESH V PH D — President and CEO, Director | Option exercise (M): 75,000 @ $21.58 · Sale (S): 75,000 @ $100.12 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | PATEL DINESH V PH D — President and CEO, Director | Option exercise (M): 75,000 @ $21.58 · Sale (S): 75,000 @ $100.12 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Giraudo Bryan — Director | Option exercise (M): 24,000 @ $6.45 · Option exercise (M): 12,000 @ $6.98 · Sale (S): 36,000 @ $100.14 · Sale (S): 12,000 @ $100.07 · Sale (S): 6,000 @ $100 · Sale (S): 5,130 @ $100 · +2 more | EDGAR |
| 2026-04-24 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 1,460 @ $0 | EDGAR |
| 2026-04-21 | 4 | Ali Asif — Chief Financial Officer | Sale (S): 1,750 @ $105.47 | EDGAR |
| 2026-03-27 | 4 | Ali Asif — Chief Financial Officer | Option exercise (M): 19,500 @ $19.19 · Option exercise (M): 5,265 @ $12.17 · Sale (S): 24,765 @ $104.24 · Option exercise (M): 19,500 (derivative) @ $0 · Option exercise (M): 5,265 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Option exercise (M): 15,000 @ $8.04 · Sale (S): 15,000 @ $104.79 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | SELICK HAROLD E — Director | Option exercise (M): 24,000 @ $12.88 · Sale (S): 24,000 @ $105 · Option exercise (M): 24,000 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 50,000 @ $0 · Option exercise (M): 59 @ $8.58 · Sale (S): 59 @ $101 · Option exercise (M): 54,641 @ $8.58 · Sale (S): 54,641 @ $101 · Option exercise (M): 59 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-18 | 4 | Williams Lewis T — Director | Option exercise (M): 18,000 @ $10.84 · Sale (S): 18,000 @ $82.42 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Waddill William D. — Director | Option exercise (M): 20,000 @ $8.31 · Sale (S): 20,000 @ $83.68 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Ali Asif — Chief Financial Officer | Option exercise (M): 16,000 @ $19.19 · Option exercise (M): 12,000 @ $12.17 · Sale (S): 28,000 @ $83.13 · Sale (S): 18,203 @ $83.14 · Option exercise (M): 16,000 (derivative) @ $0 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Sale (S): 13,151 @ $82.42 · Option exercise (M): 5,000 @ $8.04 · Sale (S): 5,000 @ $82.28 · Option exercise (M): 5,000 @ $8.04 · Sale (S): 5,000 @ $82 · Option exercise (M): 5,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-27 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 6,000 @ $0 · Option exercise (M): 19,315 @ $4.21 · Sale (S): 19,315 @ $84.59 · Option exercise (M): 10,685 @ $4.21 · Sale (S): 10,685 @ $84 · Option exercise (M): 14,205 @ $21.58 · +7 more | EDGAR |
| 2026-01-21 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Sale (S): 9,514 @ $82.48 | EDGAR |
| 2026-01-21 | 4 | Ali Asif — Chief Financial Officer | Sale (S): 8,588 @ $82.48 | EDGAR |
| 2026-01-21 | 4 | PATEL DINESH V PH D — President and CEO, Director | Sale (S): 34,438 @ $82.48 | EDGAR |
| 2026-01-13 | 4 | SELICK HAROLD E — Director | Option exercise (M): 14,299 @ $4.21 · Option exercise (M): 14,299 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Waddill William D. — Director | Grant/award (A): 2,695 @ $0 · Grant/award (A): 3,762 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Giraudo Bryan — Director | Grant/award (A): 2,695 @ $0 · Grant/award (A): 3,762 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Williams Lewis T — Director | Grant/award (A): 2,695 @ $0 · Grant/award (A): 3,762 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | O'Dowd Sarah A — Director | Grant/award (A): 2,695 @ $0 · Grant/award (A): 3,762 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Ali Asif — Chief Financial Officer | Grant/award (A): 25,600 @ $0 · Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Grant/award (A): 25,600 @ $0 · Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | SELICK HAROLD E — Director | Grant/award (A): 2,695 @ $0 · Grant/award (A): 3,762 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PATEL DINESH V PH D — President and CEO, Director | Grant/award (A): 95,400 @ $0 · Grant/award (A): 120,200 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 440 @ $0 | EDGAR |
| 2025-11-19 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Sale (S): 2,712 @ $84.77 | EDGAR |
| 2025-10-14 | 4 | Waddill William D. — Director | Option exercise (M): 12,000 @ $6.98 · Sale (S): 4,000 @ $69.25 · Sale (S): 8,000 @ $87.81 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | Waddill William D. — Director | Sale (S): 4,000 @ $64.25 | EDGAR |
| 2025-09-18 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 620 @ $0 | EDGAR |
| 2025-08-29 | 4 | Waddill William D. — Director | Sale (S): 4,000 @ $59.25 | EDGAR |
| 2025-07-28 | 4 | PATEL DINESH V PH D — President and CEO, Director | Sale (S): 10,415 @ $54.78 | EDGAR |
| 2025-07-23 | 4 | PATEL DINESH V PH D — President and CEO, Director | Grant/award (A): 25,000 @ $0 · Sale (S): 12,859 @ $54.86 · Sale (S): 22,065 @ $55.05 · Sale (S): 17,520 @ $54.79 | EDGAR |
| 2025-07-18 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 5,000 @ $0 | EDGAR |
| 2025-06-17 | 4 | PATEL DINESH V PH D — President and CEO, Director | Gift (G): 670 @ $0 · Gift (G): 685 @ $0 | EDGAR |
| 2025-06-11 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $55.51 · Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $57.03 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | SELICK HAROLD E — Director | Option exercise (M): 10,725 @ $1.16 · Option exercise (M): 10,725 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Ali Asif — Chief Financial Officer | Sale (S): 1,756 @ $46 | EDGAR |
| 2025-03-19 | 4 | Waddill William D. — Director | Sale (S): 4,000 @ $54.25 | EDGAR |
| 2025-03-14 | 4 | MOLINA ARTURO MD — Chief Medical Officer | Option exercise (M): 28,437 @ $23.42 · Option exercise (M): 2,077 @ $38.98 · Sale (S): 30,514 @ $55.74 · Option exercise (M): 28,437 (derivative) @ $0 · Option exercise (M): 2,077 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Ali Asif — Chief Financial Officer | Option exercise (M): 15,203 @ $12.17 · Option exercise (M): 9,700 @ $19.19 · Sale (S): 24,903 @ $58.73 · Option exercise (M): 15,203 (derivative) @ $0 · Option exercise (M): 9,700 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | PATEL DINESH V PH D — President and CEO, Director | Option exercise (M): 24,000 @ $4.21 · Option exercise (M): 24,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | PATEL DINESH V PH D — President and CEO, Director | Sale (S): 5,359 @ $38.18 | EDGAR |
Recent 8-K events — Protagonist Therapeutics, Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-20 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PTGX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →